GlaxoSmithKline PLC — Director's Dealing 2016

Jan 4, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7704K

GlaxoSmithKline PLC

04 January 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc (the Company).

On 31 December 2015, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company through the annual reinvestment of dividends paid throughout 2015; calculated using an average price of £13.83 per Ordinary Share and $40.98 per ADS:

Non-Executive Director	Ordinary Shares	No. of ADSs
Sir Philip Hampton	46.839
Prof Sir Roy Anderson	1,182.404
Dr Stephanie Burns		1,036.128
Stacey Cartwright	364.492
Lynn Elsenhans		542.905
Judy Lewent		320.781
Sir Deryck Maughan		2,621.255
Dr Daniel Podolsky		1,895.600
Urs Rohner	17.420
Hans Wijers	175.329

The Company and the Non-Executive Directors were informed of these allocations on 4 January 2016.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

4 January 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEZLFBQFFEBBK